These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7706693)

  • 1. Modulation of adrenergic receptors during regression of cardiac hypertrophy.
    Matsui H; Makino N; Yano K; Nakanishi H; Hata T; Yanaga T
    J Hypertens; 1994 Dec; 12(12):1353-7. PubMed ID: 7706693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion.
    Wambolt RB; Henning SL; English DR; Bondy GP; Allard MF
    J Mol Cell Cardiol; 1997 Mar; 29(3):939-48. PubMed ID: 9152855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
    Raasch W; Bartels T; Schwartz C; Häuser W; Rütten H; Dominiak P
    J Hypertens; 2002 Dec; 20(12):2495-504. PubMed ID: 12473875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac hypertrophy induced by alpha- and beta-adrenergic receptor stimulation.
    Zimmer HG; Kolbeck-Ruhmkorff C; Zierhut W
    Cardioscience; 1995 Mar; 6(1):47-57. PubMed ID: 7605896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trandolapril dose-response in spontaneously hypertensive rats: effects on ACE activity, blood pressure, and cardiac hypertrophy.
    Jouquey S; Stepniewski JP; Hamon G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S16-8. PubMed ID: 7527096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic low-dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy.
    Makino N; Sugano M; Hata T; Taguchi S; Yanaga T
    Mol Cell Biochem; 1996; 163-164():239-45. PubMed ID: 8974063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
    Haddad GE; Blackwell K; Bikhazi A
    Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J; Zhang LF; Han C; Yu GS; Ma J
    J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of cardiac hypertrophy: experimental and clinical results.
    Motz W; Klepzig M; Strauer BE
    J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S148-52. PubMed ID: 2485021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
    Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
    Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activity and expression of the myocardial postreceptor adenylyl cyclase system in pressure overload hypertrophy in rat.
    Holmer SR; Bruckschlegel G; Schunkert H; Rataj DB; Kromer EP; Riegger GA
    Cardiovasc Res; 1996 May; 31(5):719-28. PubMed ID: 8763401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors.
    Armour JA
    Can J Cardiol; 1997 Mar; 13(3):277-84. PubMed ID: 9117916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between AT1 and alpha1-adrenergic receptors in cardiomyopathic hamsters.
    Crespo MJ
    J Card Fail; 2000 Sep; 6(3):257-63. PubMed ID: 10997753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent dissociation of ACE-inhibitor effects on blood pressure, cardiac hypertrophy, and beta-adrenergic signal transduction.
    Böhm M; Castellano M; Agabiti-Rosei E; Flesch M; Paul M; Erdmann E
    Circulation; 1995 Nov; 92(10):3006-13. PubMed ID: 7586271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective downregulation of rat cardiac beta 1-adrenoceptors by cyclosporine A: prevention by diltiazem or angiotensin-converting enzyme inhibitors.
    Brodde OE; Adamczyk M; Busch F; Bossaller C; Duske E; Fleck E; Götze S; Auch-Schwelk W
    J Am Coll Cardiol; 1995 Mar; 25(3):761-7. PubMed ID: 7860926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.